TY - JOUR
T1 - "I Want to Be One Less"
T2 - The Rhetoric of Choice in Gardasil Ads
AU - Branson, Carolina Fernandez
PY - 2012/4
Y1 - 2012/4
N2 - It is nearly impossible to watch television without encountering advertisements for pharmaceuticals that purport to ease a plethora of medical concerns. From restless leg syndrome to heartburn, there are new drugs available for a wide variety of health-related conditions. One of the more controversial remedies on this list is the Gardasil vaccine. Gardasil was designed by the drug company Merck to protect against 4 strains of the sexually transmitted disease human papillomavirus. According to the Gardasil website, one of the human papillomavirus strains that Gardasil protects against causes 70% of cervical cancers. Marketing Gardasil as a miracle product and an anticancer vaccine, Merck in 2006 launched a massive public relations campaign to encourage all young women between 9 and 26 years of age to receive Gardasil.
AB - It is nearly impossible to watch television without encountering advertisements for pharmaceuticals that purport to ease a plethora of medical concerns. From restless leg syndrome to heartburn, there are new drugs available for a wide variety of health-related conditions. One of the more controversial remedies on this list is the Gardasil vaccine. Gardasil was designed by the drug company Merck to protect against 4 strains of the sexually transmitted disease human papillomavirus. According to the Gardasil website, one of the human papillomavirus strains that Gardasil protects against causes 70% of cervical cancers. Marketing Gardasil as a miracle product and an anticancer vaccine, Merck in 2006 launched a massive public relations campaign to encourage all young women between 9 and 26 years of age to receive Gardasil.
UR - http://www.scopus.com/inward/record.url?scp=84861937372&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861937372&partnerID=8YFLogxK
U2 - 10.1080/10714421.2012.674462
DO - 10.1080/10714421.2012.674462
M3 - Article
AN - SCOPUS:84861937372
SN - 1071-4421
VL - 15
SP - 144
EP - 158
JO - Communication Review
JF - Communication Review
IS - 2
ER -